Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mann

Showing results (821-830 of 909) with videos related to

Pageof 91
Sort By:
The European Respiratory Journal|April 4, 2024
Adverse pregnancy outcomes and pharyngeal flow limitation during sleep: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-be (nuMoM2b)Raichel M Alex, Dwayne L Mann, Ali Azarbarzin, et al.
European Journal of Clinical Investigation|February 26, 2019
Pulse pressure and prognosis in patients with heart failure with reduced ejection fractionNeeraj Shah, Min Qian, Marco R Di Tullio, et al.
Journal of Cardiac Failure|December 28, 2021
Frailty Measures of Patient-reported Activity and Fatigue May Predict 1-year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL RegistryAnuradha Lala, Palak Shah, Shokoufeh Khalatbari, et al.
JAMA|August 3, 2016
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialKenneth B Margulies, Adrian F Hernandez, Margaret M Redfield, et al.
Journal of the Pediatric Infectious Diseases Society|March 16, 2022
Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 PandemicKarl W Boehme, Joshua L Kennedy, Jessica Snowden, et al.
Circulation. Heart Failure|May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI TrialKarola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2019
Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL): Rationale, design, baseline characteristics, and inclusion criteria performanceKeith D Aaronson, Garrick C Stewart, Francis D Pagani, et al.
European Heart Journal|June 18, 2015
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)Stefan D Anker, Andrew J S Coats, Gabriel Cristian, et al.
Circulation|March 17, 2004
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)Douglas L Mann, John J V McMurray, Milton Packer, et al.
JACC. Heart Failure|February 7, 2021
Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart FailureAnuradha Lala, Keyur B Shah, David E Lanfear, et al.
Pageof 91

Showing results (821-830 of 909) with videos related to

Sort By:
Pageof 91
The European Respiratory Journal|April 4, 2024
Adverse pregnancy outcomes and pharyngeal flow limitation during sleep: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-be (nuMoM2b)Raichel M Alex, Dwayne L Mann, Ali Azarbarzin, et al.
European Journal of Clinical Investigation|February 26, 2019
Pulse pressure and prognosis in patients with heart failure with reduced ejection fractionNeeraj Shah, Min Qian, Marco R Di Tullio, et al.
Journal of Cardiac Failure|December 28, 2021
Frailty Measures of Patient-reported Activity and Fatigue May Predict 1-year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL RegistryAnuradha Lala, Palak Shah, Shokoufeh Khalatbari, et al.
JAMA|August 3, 2016
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialKenneth B Margulies, Adrian F Hernandez, Margaret M Redfield, et al.
Journal of the Pediatric Infectious Diseases Society|March 16, 2022
Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 PandemicKarl W Boehme, Joshua L Kennedy, Jessica Snowden, et al.
Circulation. Heart Failure|May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI TrialKarola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2019
Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL): Rationale, design, baseline characteristics, and inclusion criteria performanceKeith D Aaronson, Garrick C Stewart, Francis D Pagani, et al.
European Heart Journal|June 18, 2015
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)Stefan D Anker, Andrew J S Coats, Gabriel Cristian, et al.
Circulation|March 17, 2004
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)Douglas L Mann, John J V McMurray, Milton Packer, et al.
JACC. Heart Failure|February 7, 2021
Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart FailureAnuradha Lala, Keyur B Shah, David E Lanfear, et al.
Pageof 91